Showing results (131-140 of 162) with videos related to

Sort By:
Pageof 17
Journal of Human Immunity|January 29, 2026
Neurodevelopmental outcomes following hematopoietic cell transplantation for patients with severe combined immunodeficiency (SCID): A PIDTC studyVirdette L Brumm, Sharon A Kidd, Brent R Logan, et al.
The Journal of Allergy and Clinical Immunology|January 30, 2024
Allogeneic hematopoietic cell transplantation is effective for p47phox chronic granulomatous disease: A Primary Immune Deficiency Treatment Consortium studyEyal Grunebaum, Danielle E Arnold, Brent Logan, et al.
The New England Journal of Medicine|July 31, 2014
Transplantation outcomes for severe combined immunodeficiency, 2000-2009Sung-Yun Pai, Brent R Logan, Linda M Griffith, et al.
Transplantation and Cellular Therapy|October 4, 2025
Umbilical Cord Blood Transplantation Provides an Alternative for Patients With Chronic Granulomatous Disease Lacking HLA-Matched Donors: A PIDTC ReportDanielle E Arnold, Jennifer W Leiding, Brent Logan, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 5, 2018
Hematopoietic Stem Cell Transplantation as Treatment for Patients with DOCK8 DeficiencySusanne E Aydin, Alexandra F Freeman, Waleed Al-Herz, et al.
The New England Journal of Medicine|October 9, 2014
A modified γ-retrovirus vector for X-linked severe combined immunodeficiencySalima Hacein-Bey-Abina, Sung-Yun Pai, H Bobby Gaspar, et al.
Blood|July 21, 2023
Outcomes of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndromeRoxane Labrosse, Julia I Chu, Myriam A Armant, et al.
The Journal of Allergy and Clinical Immunology|April 30, 2026
Clinical features, genetics, treatment, and long-term outcomes of STAT3 hyper-IgE syndrome: a single-center cohort analysisAlexandra F Freeman, Chen Wang, Amanda Urban, et al.
Frontiers in Immunology|October 19, 2017
Corrigendum: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin ContentKerry Dobbs, Giovanna Tabellini, Enrica Calzoni, et al.
Frontiers in Immunology|August 4, 2017
Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin ContentKerry Dobbs, Giovanna Tabellini, Enrica Calzoni, et al.
Pageof 17